Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Ischemia-reperfusion injury remains unsolved critical issue which lacks any specific prevention and treatment under the era of development in revascularization. Here, we found novel disease mechanisms of ischemia-reperfusion injury by comprehensively analyzing bioactive lipid metabolites (lipid mediators), which we have developed as LC/MS/MS system-based metabololipidomics. These findings unveil a detailed pathological mechanism of ischemia-reperfusion organ injury and suggest a novel therapeutic approach.
|